Stock Research for ENZN

Current Price


Latest Update: 2018-03-19 09:31:00

$ 0.2820
$ 0.2820
$ 0.2820

Featured Broker: TradeStation

Get the due diligence for another stock.


ENZN Stock Chart & Research Data

The ENZN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ENZN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ENZN Due diligence Resources & Stock Charts

The ENZN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ENZN Detailed Price Forecast - CNN Money CNN View ENZN Detailed Summary - Google Finance
Yahoo View ENZN Detailed Summary - Yahoo! Finance Zacks View ENZN Stock Research & Analysis -

Stock Analysis

TradeIdeas View ENZN Trends & Analysis - Trade-Ideas Barrons View ENZN Major Holders - Barrons
NASDAQ View ENZN Call Transcripts - NASDAQ Seeking View ENZN Breaking News & Analysis - Seeking Alpha
Spotlight View ENZN Annual Report - OTC Report View ENZN OTC Short Report -
TradeKing View ENZN Fundamentals - TradeKing Charts View ENZN SEC Filings - Bar Chart
WSJ View Historical Prices for ENZN - The WSJ Morningstar View Performance/Total Return for ENZN - Morningstar
MarketWatch View the Analyst Estimates for ENZN - MarketWatch CNBC View the Earnings History for ENZN - CNBC
StockMarketWatch View the ENZN Earnings - StockMarketWatch MacroAxis View ENZN Buy or Sell Recommendations - MacroAxis
Bullish View the ENZN Bullish Patterns - American Bulls Short Pains View ENZN Short Pain Metrics -

Social Media Mentions

StockTwits View ENZN Stock Mentions - StockTwits PennyStocks View ENZN Stock Mentions - PennyStockTweets
Twitter View ENZN Stock Mentions - Twitter Invest Hub View ENZN Investment Forum News - Investor Hub
Yahoo View ENZN Stock Mentions - Yahoo! Message Board Seeking Alpha View ENZN Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ENZN - Insider Cow View Insider Transactions for ENZN - Insider Cow
CNBC View ENZN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ENZN - OTC Markets
Yahoo View Insider Transactions for ENZN - Yahoo! Finance NASDAQ View Institutional Holdings for ENZN - NASDAQ

Stock Charts

FinViz View ENZN Stock Insight & Charts - StockCharts View ENZN Investment Charts -
BarChart View ENZN Stock Overview & Charts - BarChart Trading View View ENZN User Generated Charts - Trading View

Latest Financial News for ENZN

Independent Research on Trending Growth Companies: Vet Online Supply and Enzon Pharmaceuticals
Posted on Monday March 05, 2018

NEW YORK, NY / ACCESSWIRE / March 5 , 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of Vet Online Supply, Inc. ( OTC PINK: VTNL) and Enzon Pharmaceuticals ...

Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 18, 2017
Posted on Thursday May 18, 2017

Categories: Yahoo FinanceGet free summary analysis Enzon Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Enzon Pharmaceuticals, Inc. – Nektar Therapeutics, Amgen Inc., Enanta Pharmaceuticals, Inc., Pfizer Inc., Merck & Co., Inc., Valeant Pharmaceuticals International Inc, XOMA Corporation, SciClone Pharmaceuticals, Inc., Gilead Sciences, ... Read more (Read more...)

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Enzon Pharmaceuticals Inc.
MarketWatch - Aug 15, 2016
CORRECT:Icahn suggests Enzon consider strategic review, sale. Mar. 14, 2008 at 1:08 p.m. ET; by Wallace Witkowski. CORRECT: Icahn buys Enzon stake because shares undervalued. Mar. 14, 2008 at 1:07 p.m. ET; by Wallace Witkowski. CORRECT: Carl Icahn ...

Enzon Pharmaceuticals Selling Well Below Likely Future Distributions
Seeking Alpha - May 25, 2016
Enzon Pharmaceuticals (NASDAQ:ENZN), formerly a development-stage darling, is now a $17 million market cap cigar-butt, which receives royalties on several drugs.

Enzon Pharmaceuticals: Remaining Royalties Priced In, But Door Still Open To ...
Seeking Alpha - Apr 17, 2017
Enzon Pharmaceuticals is winding down operations, distributing royalties on legacy products before its last patent expires in 2021.

Enzon Pharmaceuticals Inc (OTCMKTS:ENZN): Icahn's Done His Sums
Insider Financial - Dec 2, 2016
As per the latest financial statement (third quarter 2016) the drug, which is commercialized and marketed by pharma giant Merck & Co.

Enter a stock symbol to view the stock details.